Not logged in Share Save
[18F]FDG PET/MRI FOR ASSESSING TREATMENT RESPONSE OF CNS LYMPHOMA: A PROSPECTIVE CASE SERIES Lopez-Pereira, P.; Pons-Escoda, A.; Suarez, M.; Domingo-Domenech, E.; Martinez-Ramos, C.; Majos, C.; Gonzalez-Barca, E.; Villalobos, M.; Vidal, N.; Plans, G.; Bruna, J.; Cortes-Romera, M.; Sureda, A.; Velasco, R. Share Save
Share Save
Share Save
Share Save
Lung cancer patients' comorbidities and attendance of German ambulatory physicians in a 5-year cross-sectional study Bossert, Jasmin; Ludwig, Marion; Wronski, Pamela; Koetsenruijter, Jan; Krug, Katja; Villalobos, Matthias; Jacob, Josephine; Walker, Jochen; Thomas, Michael; Wensing, Michel Share Save
IMbrave150: Management of adverse events of special interest (AESIs) for atezolizumab (atezo) and bevacizumab (bev) in unresectable HCC Ikeda, M.; Zhu, A. X.; Qin, S.; Kim, T-Y.; Lim, H. Y.; Kudo, M.; Breder, V.; Merle, P.; Kaseb, A.; Li, D.; Ma, N.; Villalobos, M.; Stanzel, S.; Gaillard, V. E.; Xu, D-Z.; Hernandez, S.; Cheng, A-L.; Finn, R. S.; Galle, P. R.; Ducreux, M. P. Share Save
Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group Muntanola, A.; Baumann, T.; Caballero, A. C.; Sanchez-Gonzalez, B.; Mercadal, S.; Escoda, L.; Soler, A.; Iserte, L.; Canet, M.; Villalobos, M. T.; Magnano, L.; Sorigue, M.; Garcia, O.; Salar, A.; Lopez-Guillermo, A.; Sancho, J. M. Share Save
Share Save
Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancer Thomas, Michael; Fischer, Juergen; Andreas, Stefan; Kortsik, Cornelius; Grah, Christian; Serke, Monika; von Eiff, Michael; Witt, Christian; Kollmeier, Jens; Mueller, Ernst; Schenk, Michael; Schroeder, Michael; Villalobos, Matthias; Reinmuth, Niels; Penzel, Roland; Schnabel, Philipp; Acker, Thomas; Reuss, Alexander; Wolf, Martin Share Save
Share Save